|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation | |||||
| Settlement and patent license income | |||||
| Foreign currency remeasurement loss | |||||
| Deferred income taxes | |||||
| Gain (loss) on sale of property and equipment | |||||
| Accounts receivable charges | |||||
| Amortization of premium on marketable securities | |||||
| Realized loss on marketable securities | |||||
| Noncash interest expense | |||||
| Impairment of investment | |||||
| Noncash capital contributions from parent | |||||
| Noncash restructuring charges | |||||
| Changes in operating assets and liabilities, net of amounts acquired: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Income taxes receivable | |||||
| Other assets | |||||
| Accounts payable and other current liabilities | |||||
| Deferred revenue | |||||
| Income taxes payable | |||||
| Payments related to litigation, net | |||||
| Other long term liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Investing activities | |||||
| Purchases of marketable securities | |||||
| Sale and maturities of marketable securities | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Cash acquired in (used for) acquisition of business | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Proceeds from issuance of debt, net | |||||
| Purchase of capped calls | |||||
| Payment of debt issuance costs | |||||
| Proceeds from financing obligations | |||||
| Repayment of financing obligations | |||||
| Payment of employee tax withholdings related to restricted stock vesting | |||||
| Cash paid for the purchase of common stock | |||||
| Proceeds from employee stock plans | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplement disclosure of cash flow information | |||||
| Cash paid during the year for interest | |||||
| Cash paid during the year for income taxes, net of refunds | |||||
| Common stock issued in connection with acquisition of business | |||||
| Common stock contingent consideration related to business combination | |||||
| Common stock issued for employee compensation arrangements | |||||
| Property and equipment included in accounts payable and other current liabilities | |||||
| Noncash additions to financing receivables | |||||
| Noncash additions to short-term financing liabilities | |||||
| Noncash additions to long-term financing liabilities | |||||
Loading...